Publications - 'P'
Publications 251 - 275 de 2458
Titre | DOI |
---|---|
Patient preference of trastuzumab administration (SC versus IV) in HER2-positive metastatic breast cancer: Results of the randomised Metaspher study X. Pivot; J.P. Spano; E. Marc; P. Cottu; C. Jouannaud; V. Pottier; L. Moreau; J.M. Extra; A. Lortholary; P. Rivera; D. Spaeth; H. Attar-Rabia; C. Benkamoun; L. Dima-Martinez; N. Esposito; J. Gligorov 2016 |
10.1093/annonc/mdw365.53 |
Patient reactions to drug delisting L. Briquet 2021 |
10.1016/j.actpha.2021.06.014 |
Patient safety in external beam radiotherapy - Guidelines on risk assessment and analysis of adverse error-events and near misses: Introducing the ACCIRAD project J. Malicki; R. Bly; M. Bulot; J.L. Godet; A. Jahnen; M. Krengli; P. Maingon; C.Prieto Martin; K. Przybylska; A. Skrobala; M. Valero; H. Jarvinen; ESTRO 2014 |
10.1016/j.radonc.2014.08.011 |
Patient safety: determine high risk factor of medication discrepancies to target patient reconciled in geriatric pathway G. Barbier; A.L. Clairet; B. Gerard; S. Koeberle; B. Contreras; V. Nerich; S. Limat 2019 |
|
Patient satisfaction with a rapid diagnosis of suspicious breast lesions: Association with distress and anxiety D. Boinon; S. Dauchy; C. Charles; L. Fasse; A. Cano; C. Balleyguier; C. Mazouni; H. Caron; P. Vielh; S. Delaloge 2018 |
10.1111/tbj.12856 |
Patient's satisfaction at 2 years after groin hernia repair: any difference according to the technique? B. Romain; J.F. Gillion; P. Ortega-Deballon; N. Meyer; C. Hernie 2018 |
10.1007/s10029-018-1796-y |
PATIENT'S VERSION OF THE RECOMMENDATIONS OF THE FRENCH SOCIETY OF RHEUMATOLOGY (SFR) FOR SUPPORT IN CURRENT PRACTICE OF PATIENTS WITH SPONDYLOARTHRITIS L. Grange; L. Carton; J.N. Dachicourt; R. Diebold; M. Faugere; A. Froukhi; F. Laloyaux; G. Schmidt; S. Zaoui; D. Wendling 2015 |
10.1136/annrheumdis-2015-eular.4845 |
Patient-Centered Care in Breast Cancer Genetic Clinics A. Bredart; A. Anota; J. Dick; V. Kuboth; O. Lareyre; A. de Pauw; A. Cano; D. Stoppa-Lyonnet; R. Schmutzler; S. Dolbeault; J.L. Kop 2018 |
10.3390/ijerph15020319 |
Patient-perceived flares in rheumatoid arthritis: A sub-analysis of the STRASS treatment tapering strategy trial A. Portier; L. Gossec; F. Tubach; T. Alfaiate; T. Pham; A. Saraux; M. Soubrier; T. Schaeverbeke; J.F. Maillefert; X. Mariette; D. Hajage; B. Fautrel 2017 |
10.1016/j.jbspin.2016.10.001 |
Patient-reported outcomes (PROs) from MARIANNE: A phase III study of trastuzumab emtansine (T-DM1) +/- pertuzumab (P) vs trastuzumab plus taxane (HT) for HER2-positive advanced breast cancer. C.H. Barrios; D. Cella; M. Martin; W. Eiermann; H.A. Burris; Y.H. Im; P.Franco Conte; M. Toi; T. Pienkowski; X.B. Pivot; B. Beckermann; S.Franz Stanzel; J. Petersen; P.Anthony Ellis 2016 |
10.1200/JCO.2016.34.15_suppl.593 |
Patient-Reported Outcomes (PROs) in randomized controlled trials of colorectal cancers. methodological quality of reporting over time F. Sparano; J. Rees; J. Blazeby; M. Pezold; A.L. Pusic; N.K. Aaronson; M. Sprangers; P. Fayers; N. Deliu; A. Anota; F. Efficace; G.I.M.E.M.A.E.O.R.T.C.Qual Grp 2017 |
|
Patient-Reported Outcomes (PROs) in randomized controlled trials of colorectal cancers. methodological quality of reporting over time F. Sparano; J. Rees; J. Blazeby; M. Pezold; A.L. Pusic; N.K. Aaronson; M. Sprangers; P. Fayers; N. Deliu; A. Anota; F. Efficace; G.I.M.E.M.A.E.O.R.T.C.Qual Grp 2017 |
|
Patient-Reported Outcomes as Independent Prognostic Factors for Survival in Oncology: Systematic Review and Meta-Analysis F. Efficaee; G.S. Collins; F. Cottone; J.M. Giesinger; K. Sommer; A. Anota; M.Maia Schlussel; P. Fazi; M. Vignetti 2021 |
10.1016/j.jval.2020.10.017 |
Patient-Reported Outcomes Enhance the Survival Prediction of Traditional Disease Risk Classifications: An International Study in Patients With Myelodysplastic Syndromes F. Efficace; F. Cottone; G. Abel; P. Niscola; G. Gaidano; F. Bonnetain; A. Anota; G. Caocci; A. Cronin; L. Fianchi; M. Breccia; R. Stauder; U. Platzbecker; G.A. Palumbo; M. Luppi; R. Invernizzi; M. Bergamaschi; L. Borin; A.Angela Di Tucci; H. Zhang; M. Sprangers; M. Vignetti; F. Mandelli 2018 |
10.1002/cncr.31193 |
Patient-reported outcomes in lupus clinical trials with biologics N. Annapureddy; H. Devilliers; M. Jolly 2016 |
10.1177/0961203316652494 |
Patient-reported outcomes monitoring dramatically improves therapy adherence and overall survival in ibrutinib-exposed patients: a retrospective study from the FILO group A.S. Michallet; L. Ysebaert; E. Ferrant; L. Loison; A. Quinquenel; F. Bijou; A. Brion; L. Kamel; R. Guieze; A. Clavert; A. Teste 2020 |
|
Patients & rsquo; real-world experience with inflammatory bowel disease: A cross-sectional survey in tertiary care centres from the GETAID group * M. Nachury; Y. Bouhnik; M. Serrero; J. Filippi; X. Roblin; J. Kirchgesner; G. Bouguen; D. Franchimont; G. Savoye; A. Buisson; E. Louis; S. Nancey; V. Abitbol; J.M. Reimund; O. DeWit; L. Vuitton; N. Matthieu; L. Peyrin-Biroulet; C. Gilletta; S. Tadbiri; M. Allez; S. Viennot; A. Bourreille; D. Laharie; A. Amiot; G.E.T.A.I.D.P.Experience Study 2021 |
10.1016/j.dld.2020.10.020 |
Patients eligible for proprotein convertase subtilisin/kexin type9 inhibitors (pcsk9i) after acute myocardial infarction. The ESC position applied to patients included in the FAST-MI 2015 registry F. Schiele; E. Puymirat; J. Ferrieres; S. Onceanu; T. Beard; X. Marchand; J. Landel; N. Meneveau; T. Simon; N. Danchin 2019 |
|
Patients eligible for proprotein convertase subtilisin/kexin type9 inhibitors (pcsk9i) after acute myocardial infarction. The ESC position applied to patients included in the FAST-MI 2015 registry F. Schiele; E. Puymirat; J. Ferrieres; S. Onceanu; T. Beard; X. Marchand; J. Landel; N. Meneveau; T. Simon; N. Danchin 2019 |
|
Patients treated for HCV and listed for LT in a French multicenter study: what happens at 3 years L. Meunier; G.P. Pageaux; S. Radenne; V.A. Pichard; P. Houssel-Debry; C. Duvoux; D. Botta-Fridlund; V. De Ledinghen; F. Conti; R. Anti; V. Di Martino; M. Debette-Gratien; V. Leroy; P. Lebray; L. Alric; A. Abergel; J. Dumortier; C. Besch; H. Montialoux; D. Samuel; J.C. Duclos-Vallee; A. Coilly 2019 |
|
Patients treated for HCV and listed for LT in a French multicenter study: What happens at 3 years? L. Meunier; G.P. Pageaux; S. Radenne; A.Vallet Pichard; P. Houssel-Debry; C. Duvoux; D.Botta Fridlund; V. de Ledinghen; F. Conti; R. Anty; V. Di Martino; M. Gratien; V. Leroy; P. Lebray; L. Alric; A. Abergel; J. Dumortier; C. Besch; M. Helene; D. Samuel; J.C. Duclos-Vallee; A. Coilly 2019 |
|
Patients With Acute Liver Failure Listed for Superurgent Liver Transplantation in France: Reevaluation of the Clichy-Villejuif Criteria P. Ichai; C. Legeai; C. Francoz; K. Boudjema; O. Boillot; C. Ducerf; P. Mathurin; F.R. Pruvot; B. Suc; P. Wolf; O. Soubrane; Y.Patrice Le Treut; D. Cherqui; L. Hannoun; G.P. Pageaux; J. Gugenheim; C. Letoublon; J. Saric; V. Di Martino; A. Abergel; L. Chiche; T.Maria Antonini; C. Jacquelinet; D. Castaing; D. Samuel; F.Liver Tran Teams 2015 |
10.1002/lt.24092 |
Patients With Colorectal Tumors With Microsatellite Instability and Large Deletions in HSP110 T-17 Have Improved Response to 5-Fluorouracil-Based Chemotherapy A. Collura; A. Lagrange; M. Svrcek; L. Marisa; O. Buhard; A. Guilloux; K. Wanherdrick; C. Dorard; A. Taieb; A. Saget; M. Loh; R. Soong; N. Zeps; C. Platell; A. Mews; B. Iacopetta; A. de Thonel; R. Seigneuric; G. Marcion; C. Chapusot; C. Lepage; A.M. Bouvier; M.P. Gaub; G. Milano; J. Selves; P. Senet; P. Delarue; H. Arzouk; C. Lacoste; A. Coquelle; L. Bengrine-Lefevre; C. Tournigand; J.H. Lefevre; Y. Parc; D.S. Biard; J.F. Flejou; C. Garrido; A. Duval 2014 |
10.1053/j.gastro.2013.10.054 |
Patients with Coronavirus 2019 (COVID-19) and Surgery: Guidelines and Checklist Proposal M. Grelat; B. Pommier; S. Portet; A. Amelot; C. Barrey; H.A. Leroy; R. Madkouri 2020 |
10.1016/j.wneu.2020.04.155 |
Patients with dual MPO- and PR3-ANCA do not present primary systemic necrotizingvasculitis A.S. Denomme; D. Lakomy; N. Olsson; J.F. Augusto; J.F. Subra; X. Puechal; A. Chevailler 2015 |
10.1016/j.jbspin.2014.11.004 |